SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-102532
Filing Date
2021-03-31
Accepted
2021-03-31 17:20:33
Documents
4
Effectiveness Date
2021-03-31

Document Format Files

Seq Description Document Type Size
1 S-8 d143421ds8.htm S-8 74655
2 EX-5.1 d143421dex51.htm EX-5.1 8913
3 EX-23.1 d143421dex231.htm EX-23.1 1629
4 GRAPHIC g143421dsp1.jpg GRAPHIC 2051
  Complete submission text file 0001193125-21-102532.txt   89159
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254932 | Film No.: 21794684
SIC: 2836 Biological Products, (No Diagnostic Substances)